Georg Mellitzer

6PUBLICATIONS
5CO-AUTHORS
Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Correction: Blanchet et al. Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair. Cancers 2021, 13, 916.

|Dec 19, 2022
Morpho-functional analysis of patient-derived xenografts reveals differential impact of gastric cancer and chemotherapy on the tumor ecosystem, affecting immune check point, metabolism, and sarcopenia.

A Venkatasamy, E Guerin, W Reichardt

|Nov 11, 2022
Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?

Amandine Badie, Christian Gaiddon, Georg Mellitzer

|Sep 23, 2022
The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response.

Justine De Azevedo, Jana Mourtada, Cyril Bour

|Sep 28, 2021
Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer.

Aina Venkatasamy, Eric Guerin, Anais Blanchet

|Sep 10, 2021
Bypassing the Resistance Mechanisms of the Tumor Ecosystem by Targeting the Endoplasmic Reticulum Stress Pathway Using Ruthenium- and Osmium-Based Organometallic Compounds: An Exciting Long-Term Collaboration with Dr. Michel Pfeffer.

Christian Gaiddon, Isabelle Gross, Xiangjun Meng

Pageof 1

Frequent Collaborators

5 joint publications

Christian Gaiddon

2 joint publications

Véronique Devignot

1 joint publications

Isabelle Gross

1 joint publications

Aina Venkatasamy